Table 3 Antibiotic susceptibility pattern of ESBL producing Escherichia coli
Antibiotics | S (%) | I (%) | R (%) |
|---|---|---|---|
Amikacin | 32 (45.71) | 6 (8.71) | 32 (45.43) |
Ampicillin | 0 (0.00) | 0 (0.00) | 70 (100.00) |
Amoxicillin–clavulanic acid | 25 (35.71) | 7 (10.00) | 38 (54.29) |
Aztreonam | 3 (4.29) | 0 (0.00) | 67 (95.71) |
Ceftriaxone | 10 (14.29) | 2 (2.86) | 58 (82.86) |
Cefotaxime | 5 (7.14) | 2 (2.86) | 63 (90.00) |
Ceftazidime | 7 (10.00) | 2 (2.86) | 61 (87.14) |
Chloramphenicol | 0 (0.00) | 0 (0.00) | 70 (100.00) |
Ciprofloxacin | 15 (21.43) | 3 (4.29) | 52 (74.29) |
Ertapenem | 65 (92.86) | 0 (0.00) | 5 (7.14) |
Gentamicin | 21 (30.00) | 4 (5.71) | 45 (64.29) |
Imipenem | 68 (97.14) | 1 (1.43) | 1 (1.43) |
Meropenem | 65 (92.86) | 1 (1.43) | 4 (4.29) |
Nitrofurantoin | 39 (55.71) | 4 (5.71) | 27 (38.57) |
Ofloxacin | 26 (37.14) | 0 (0.00) | 44 (62.86) |
Piperacillin/tazobactam | 42 (60.00) | 4 (5.71) | 24 (34.29) |
Tetracycline | 0 (0.00) | 0 (0.00) | 70 (100.00) |